Top Markets
Coin of the day
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

600866
Rankning i aktier #9223
Established in 1964 and headquartered in Zhaoqing, China, Star Lake Bioscience... Established in 1964 and headquartered in Zhaoqing, China, Star Lake Bioscience Co., Inc. specializes in the production and global distribution of pharmaceutical ingredients, as well as food and animal feed additives. Its extensive product catalog includes guanosine, which serves as a crucial intermediate for both food and pharmaceutical applications. The company also manufactures L-proline, a vital intermediate for synthesizing captopril and enalapril, and a raw material used in amino acid transfusions. Another key offering is Adefovir dipivoxil tablets, formulated to combat Hepatitis B by inhibiting HBV DNA polymerase activity and disrupting the virus's DNA. Additionally, L-threonine is provided for its application in animal feed premixes, particularly for pigs and poultry. Star Lake Bioscience further supplies disodium 5'-ribonucleotide, utilized in the treatment of chronic hepatitis, muscular atrophy, and certain eye conditions. Similarly, disodium 5-inosinate addresses issues like leukopenia, thrombocytopenia, and both acute and chronic hepatitis. Inosine is another significant product, prescribed for various ailments including chronic hepatitis, heart disease, low white blood cell or platelet counts, and central choroidoretinitis. Furthermore, disodium 5'-guanylate finds application in food preservation, such as for canned meats, ham, and other salted meat products. The company's broad portfolio also features compounds such as ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, and L-lysine, among others. These diverse offerings are marketed under the proprietary brands Star Lake and Yue Bao.
Aktiekurs
$0.63907023
Senast synkroniserad: 2026-08-28
Marknadsvärde
$1.06B
Förändring (1 dag)
1.15%
Förändring (1 år)
-44.43%
Land
CN
Handel Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866)

Kategori

Vinst för Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Star Lake Bioscience Co., Inc.Zhaoqing Guangdong är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Star Lake Bioscience Co., Inc.Zhaoqing Guangdong från 2026 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
Inte tillräckligt med data för de angivna datumen.
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$5.27B -
US
$1.95B -
NL
$-4.02B -
AU
$-3.09B -
US
- -
CH